Literature DB >> 27558382

Persistence of Porphyromonas gingivalis is a negative predictor in patients with moderate to severe periodontitis after nonsurgical periodontal therapy.

Sigrun Eick1, Ayse Mathey2, Karolin Vollroth3, Martin Kramesberger3, Walter Bürgin4, Anton Sculean2, Christoph Ramseier2, Holger Jentsch3.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the quality of prediction for stable results after nonsurgical periodontal therapy by several microbiological variables of the subgingival biofilm and biomarkers of gingival crevicular fluid or oral lavage.
MATERIAL AND METHODS: Forty-six individuals with moderate or severe chronic periodontitis receiving nonsurgical periodontal therapy were monitored for clinical variables, selected microorganisms, and biomarkers at baseline and 3 and 6 months thereafter. Logistic regression analysis and general linear model (GLM) were applied for analysis of variance and covariance.
RESULTS: At 6 months, 20 patients showed a high response (HR) to treatment (at least 60 % of reduction of numbers of sites with PD >4 mm), whereas 26 did not (low response, LR). All clinical variables were significantly improved at 3 and 6 months within each group (p < 0.001, each compared with baseline). Modeling the impact of Porphyromonas gingivalis, Treponema denticola, and median of MMP-8 on to the response to treatment as continuous variables by GLM showed a significant influence of these variables (p = 0.045) with the strongest influence of P. gingivalis (p = 0.012) followed by T. denticola (p = 0.045) and no association with MMP-8 (p = 0.982). Samples tested positively for P. gingivalis decreased only in HR (3 months: p = 0.003; 6 months: p = 0.002). Calprotectin levels in GCF were lower in the HR group compared with the LR group at 3 months (p = 0.008) and at 6 months (p = 0.018).
CONCLUSION: Persistence of P. gingivalis combined with a high GCF level of calprotectin may have a negative predictive value on response to periodontal therapy. CLINICAL RELEVANCE: Microbiological diagnostics for P. gingivalis before and 3 months after SRP may have a predictive value on response to periodontal therapy. The combination with MMP-8 in oral lavage or preferably calprotectin in GCF might give additional information.

Entities:  

Keywords:  Biomarkers; Chronic periodontitis; Microbiological diagnostics; Porphyromonas gingivalis; Response to treatment

Mesh:

Substances:

Year:  2016        PMID: 27558382     DOI: 10.1007/s00784-016-1933-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  54 in total

1.  Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment.

Authors:  Sigrun Eick; Anna Straube; Arndt Guentsch; Wolfgang Pfister; Holger Jentsch
Journal:  Diagn Microbiol Infect Dis       Date:  2011-01       Impact factor: 2.803

Review 2.  Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.

Authors:  J Verstappen; J W Von den Hoff
Journal:  J Dent Res       Date:  2006-12       Impact factor: 6.116

3.  Effects of smoking on healing response to non-surgical periodontal therapy: a multilevel modelling analysis.

Authors:  Chi Pui Wan; W Keung Leung; May C M Wong; Ruby M S Wong; Peng Wan; Edward C M Lo; Esmonde F Corbet
Journal:  J Clin Periodontol       Date:  2009-03       Impact factor: 8.728

4.  Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis.

Authors:  A Badersten; R Nilvéus; J Egelberg
Journal:  J Clin Periodontol       Date:  1981-02       Impact factor: 8.728

Review 5.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

6.  Saliva/pathogen biomarker signatures and periodontal disease progression.

Authors:  J S Kinney; T Morelli; T Braun; C A Ramseier; A E Herr; J V Sugai; C E Shelburne; L A Rayburn; A K Singh; W V Giannobile
Journal:  J Dent Res       Date:  2011-03-15       Impact factor: 6.116

Review 7.  Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response.

Authors:  George Hajishengallis
Journal:  Trends Immunol       Date:  2013-10-23       Impact factor: 16.687

8.  The prevalence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in humans 1 year after 4 randomized treatment modalities.

Authors:  J Shiloah; M R Patters; J W Dean; P Bland; G Toledo
Journal:  J Periodontol       Date:  1998-12       Impact factor: 6.993

9.  Estimation of Specific Salivary Enzymatic Biomarkers in Individuals with Gingivitis and Chronic Periodontitis: A Clinical and Biochemical Study.

Authors:  Roji Luke; S Nubesh Khan; P Safar Iqbal; Rino Roopak Soman; Jithesh Chakkarayan; V Krishnan
Journal:  J Int Oral Health       Date:  2015-09

10.  Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver.

Authors:  Mayuka Nakajima; Kei Arimatsu; Tamotsu Kato; Yumi Matsuda; Takayoshi Minagawa; Naoki Takahashi; Hiroshi Ohno; Kazuhisa Yamazaki
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more
  1 in total

1.  Comparison of clinical parameters, microbiological effects and calprotectin counts in gingival crevicular fluid between Er: YAG laser and conventional periodontal therapies: A split-mouth, single-blinded, randomized controlled trial.

Authors:  Yue Wang; Weiwei Li; Li Shi; Fengqiu Zhang; Sun Zheng
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.